BMVC-8C3O No Further a Mystery
holding next tub software of each antagonist at a number of concentrations. We detected a borderline unequal variance across antagonist-focus teams (Levene’s examination for homogeneity of variance, FFurthermore, the ACNP poster presentation included information Formerly documented by BlackThorn exhibiting that BTRX-140 was properly tolerated in